Top compounds associated with response to TM9SF3


Feature Type Standardized
Nominal ANOVA
mRNA LE-135 CTRPv2 pan-cancer AAC -0.099 0.01
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.01
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.01
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.01
mRNA Axitinib GDSC1000 pan-cancer AAC 0.09 0.01
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA lapatinib CTRPv2 pan-cancer AAC 0.094 0.02
mRNA GSK690693 GDSC1000 pan-cancer AAC -0.079 0.02
mRNA Crizotinib CCLE pan-cancer AAC 0.11 0.02
Download CSV